The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
Official Title: A Phase IIa Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Adult Patients With Acute Myeloid Leukemia (AML)
Study ID: NCT01066494
Brief Summary: A phase IIa study to evaluate the pharmacokinetic and efficacy of amonafide L-malate (AS1413) in combination with cytarabine in treating patients with acute myeloid leukemia (AML)
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Institute of Haematology and Transfusiology, Tbilisi, , Georgia
Medulla - Chemotherapy and Immunotherapy Clinic, Tbilisi, , Georgia
Hema - Haematology and Chemotherapy Clinic, Tbilisi, , Georgia
Institure of URgent adn Recovery Surgery n.a. V.K. gusaka of Academy Medical Science of Ukraine, Donetsk, , Ukraine
Kyiv bone Marrow Transplantation Centre, Kiev, , Ukraine
Vinnytsya Regional clinical Hospital, Vinnytsya, , Ukraine